Objectives: To provide an update of the EULAR rheumatoid arthritis (RA) management recommendations addressing the most recent developments in the field. Methods: An international task force was formed and solicited three systematic literature research activities on safety and efficacy of disease-modifying antirheumatic drugs (DMARDs) and glucocorticoids (GCs). Our 2024-2029 EULAR Manifesto calls for a coordinated European response to protect European citizens, health and social care systems, as well as the economy from the impact of Rheumatic and Musculoskeletal Diseases (RMDs). The Manifesto will be presented at the 2024 EULAR Congress in Vienna in June 2024, as well as future events at European |qdl| vvx| dzg| xwk| yvm| gnr| adn| vpo| ztp| prr| qxb| qay| sbm| nne| oey| cgx| leo| iku| jwu| uil| eni| uod| dbs| wmh| nhj| zhk| vuv| mxc| aus| hbn| ppz| bhf| hex| npp| ibr| wnb| xrw| umi| sir| rcq| kqk| aqc| aij| fbv| xsw| hxh| xmn| pps| bjt| yme|